Delivery Order SPE2DB24D1205-SPE2DB25FCVWD
Award Date
4/15/25
Potential Completion Date
5/6/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Orgovyx 120 mg tablets, a medication used in the treatment of prostate cancer. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,385.52 and a period of performance through May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Orgovyx 120 mg tablets, a medication used to treat prostate cancer. The contract has a firm fixed price, a ceiling value of $5,542.08, and a period of performance through May 14, 2025. This contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,329.89, is for the delivery of the medication Orgovyx 120 mg tablet, a treatment for advanced prostate cancer. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orgovyx 120 mg tablets, a medication used to treat prostate cancer. The contract is a firm fixed-price delivery order with a ceiling value of $4,156.56 and a period of performance through May 16, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orgovyx 120 mg tablets, a medication used to treat advanced prostate cancer. The contract has a firm fixed price of $16,626.24 and a period of performance through May 29, 2025. This award is not designated as a set-aside contract, indicating open competition. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET, a medication used to treat prostate cancer. The contract has an ultimate completion date of May 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,329.89, is for the delivery of the pharmaceutical product Orgovyx 120 mg Tablet, with a performance period ending in August 2024. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,385.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the medication Orgovyx 120 mg tablet, with an ultimate completion date of May 20, 2025. The contract is not set aside and is a firm fixed-price type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a $4,156.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 mg ORGOVYX tablets, a medication used to treat advanced prostate cancer. The delivery order has a completion date of June 16, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orgovyx 120 mg tablets. The contract has a firm fixed price of $1,385.52 and a period of performance through May 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...